Reference
NICE. Pancreatic cancer patients to have routine access to life extending drug after new deal, says NICE. Internet Document : 8 Aug 2017. Available from: URL: https://www.nice.org.uk/news/article/pancreatic-cancer-patients-to-have-routine-access-to-life-extending-drug-after-new-deal-says-nice
Rights and permissions
About this article
Cite this article
UK NICE recommends nab-paclitaxel for pancreatic cancer. PharmacoEcon Outcomes News 784, 39 (2017). https://doi.org/10.1007/s40274-017-4250-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4250-y